Skip to main content

Table 2 Quality assessment of included studies

From: Non-high altitude methods for rapid screening of susceptibility to acute mountain sickness

Trials

  Criteria

Total score

 

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Huang HH [21]

0

0

1

0

1

0

1

1

0

1

1

1

1

0

0

0

1

1

1

0

1

12

9

1.33

Tian KX [35]

0

0

1

0

1

0

1

1

0

1

1

1

1

0

0

0

1

1

1

1

1

13

8

1.63

Long M [29]

0

0

1

0

1

0

1

1

0

1

1

1

1

0

0

0

0

1

1

0

1

11

10

1.1

Zhou QQ [25]

0

0

1

0

1

0

1

1

0

1

1

1

1

0

0

0

1

1

1

1

1

12

9

1.33

Wang L [46]

0

0

1

0

1

0

1

1

0

1

1

1

1

0

0

0

0

1

1

0

1

11

10

1.1

  1. Abbreviations: A Randomized controlled trial, B Method of randomization appropriate, C Study prospective, D Double-blind, E Inclusion and exclusion criteria, F Method of double-blinding appropriate, G Participants selection described, H Comparison of treatment and control or before experiment and after, I Description of withdrawals, J Models adequate, K Objectives defined, L Outcome defined, M Sample size justified, N Description of the co-interventions, O Other care identical, P Source of bias addressed, Q Raw data available, R Statistical methods described, S Published (not just abstract), T Financial support described, U quasi-experiment, V Number of yes, W Number of no, X Ratio yes/no, 1 yes, 0 no/not mentioned, N not applicable.